Cargando…
502. Telemedicine Service for Evaluation of Pediatric Outpatients at High Risk for Severe COVID-19
BACKGROUND: During the COVID-19 pandemic, neutralizing monoclonal antibody (mAb) products received emergency use authorization for treatment of mild to moderate COVID-19 in high-risk patients. Expert consensus guidance recommended individualized risk assessment when considering mAb therapies in chil...
Autores principales: | Weakley, Kathryn E, Bryant, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678235/ http://dx.doi.org/10.1093/ofid/ofad500.571 |
Ejemplares similares
-
2324. Long-Term Health Outcomes of Children Evaluated for Unexplained Fevers in a Pediatric Infectious Diseases Clinic
por: Weakley, Kathryn, et al.
Publicado: (2018) -
1959. Parent Satisfaction and Antibiotic Prescribing for Pediatric Respiratory Infections by Telemedicine
por: Foster, Charles B, et al.
Publicado: (2019) -
Utilization and Adequacy of Telemedicine for Outpatient Pediatric Surgical Care
por: Gross, Kendall, et al.
Publicado: (2022) -
2323. Pediatric Infectious Diseases Outpatient Telehealth Services During the COVID-19 Pandemic: Single Center Experience
por: Zabalo, Celisse, et al.
Publicado: (2023) -
502. Klebsiella variicola Infections in Service Members Who Sustained Trauma in Iraq and Afghanistan
por: Kiley, John L, et al.
Publicado: (2019)